Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma.

Jiang, Naomi Y; Woda, Bruce A; Banner, Barbara F; Whalen, Giles F; Dresser, Karen A; Lu, Di

Jiang, Naomi Y; Woda, Bruce A; Banner, Barbara F; Whalen, Giles F; Dresser, Karen A; Lu, Di.

Affiliation

Jiang NY; Massachusetts Institute of Technology, Cambridge, MA, USA.

Cancer Epidemiol Biomarkers Prev ; 17(7): 1648-52, 2008 Jul.

Article in En | MEDLINE | ID: mdl-18628415

Subject(s)

Biomarkers, Tumor/biosynthesis; Carcinoma, Pancreatic Ductal/metabolism; Pancreatic Neoplasms/metabolism; Sp1 Transcription Factor/biosynthesis; Aged; Carcinoma, Pancreatic Ductal/genetics; Carcinoma, Pancreatic Ductal/pathology; Female; Follow-Up Studies; Humans; Immunohistochemistry; Male; Massachusetts/epidemiology; Neoplasm Staging; Pancreatic Neoplasms/mortality; Pancreatic Neoplasms/pathology; Prognosis; Retrospective Studies; Severity of Illness Index; Survival Rate/trends

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Biomarkers, Tumor / Sp1 Transcription Factor / Carcinoma, Pancreatic Ductal Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Cancer Epidemiol Biomarkers Prev Journal subject: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Year: 2008 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google